Invirase
Links shared publicly online about this topic
ingentaconnect Invirase may interfere with heart's electrical activity
ingentaconnect.com — “ingentaconnect Invirase may interfere with heart's electrical activity” View full resource at ingentaconnect.com
Most Recently Shared on November 1, 2010 at 10:36 am By:
Drugs and Devices OW OW Health
Invirase may interfere with heart's electrical activity: (Source: Reactions) http://bit.ly/b0FLqB
New Label Changes for Commonly Prescribed HIV Drug Invirase
fda.gov — “HIV, Invirase, heart” View full resource at fda.gov
Most Recently Shared on October 21, 2010 at 4:04 pm By:
eyeonfda Pharma and Health Lawyer
FDA on New Label Changes for Commonly Prescribed HIV Drug Invirase - http://ow.ly/2XcJg
FDA Alert: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm
drugs.com — “FDA Alert: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 8:52 pm By:
FDA Alert - Labeling Change for Invirase (saquinavir) - Risk of Abnormal Heart Rhythm - http://bit.ly/9nxaPY
FDA Alert: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm
drugs.com — “FDA Alert: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 9:06 pm By:
Drugs and Devices OW OW Health
Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm: Audience: Cardiology, Infectious Disease ... http://bit.ly/at3Bk4 #FDA
Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm
fda.gov — “Prolonged QT or PR intervals reported when Invirase is used with the antiviral medication, Norvir (ritonavir).” View full resource at fda.gov
Most Recently Shared on October 21, 2010 at 7:58 pm By:
Trish D'Antonio Health Professional
Getting the word out: FDA: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm (http://bit.ly/9sMymg)
FDA Alert: Invirase (saquinavir): Ongoing safety review of clinical trial data
drugs.com — “FDA Alert: Invirase (saquinavir): Ongoing safety review of clinical trial data” View full resource at drugs.com
Most Recently Shared on February 23, 2010 at 9:30 pm By:
FDA Alert - Invirase (saquinavir): Ongoing safety review of clinical trial data - http://bit.ly/axMLC8
Invirase (saquinavir): Ongoing safety review of clinical trial data
fda.gov — “Possible association with abnormal heart rhythms when used in combination with Norvir (ritonavir).” View full resource at fda.gov
Most Recently Shared on February 25, 2010 at 11:33 am By:
Invirase (saquinavir): Ongoing safety review of clinical trial data http://tinyurl.com/yfde83n
New Label Changes For Commonly Prescribed HIV Drug Invirase
medicalnewstoday.com — “The U.S. Food and Drug Administration announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir), describing potentially life-threatening si” View full resource at medicalnewstoday.com
Most Recently Shared on October 22, 2010 at 7:05 pm By:
New Label Changes For Commonly Prescribed HIV Drug Invirase http://mnt.to/3LCR #hivaids
Symposier - Review of HIV medication Invirase (saquinavir) and Cardiac Arrhythmias
symposier.com — “Uploaded and Shared in Youtube by: USFoodandDrugAdmin FDA is reviewing clinical trial data suggesting that using Invirase (saquinavir) in combination with Norvir (ritonavir) may increase the risk of cardiac arrhythmias. Invirase and Norvir are protease inhibitors used in combination to treat HIV infection. The study was conducted by Roche, the manufacturer of Invirase, in response to FDA's request that all manufacturers of protease inhibitors evaluate the effect of these drugs on QT and PR ” View full resource at symposier.com
Most Recently Shared on May 24, 2010 at 10:17 pm By:
Symposier Cardiology Cardiology and Health Business
Review of HIV medication Invirase (saquinavir) and Cardiac Arrhythmias. http://bit.ly/9rZAqS
Invirase labeling updated to include cardiac risk with Norvir - ONA
oncologynurseadvisor.com — “The FDA announced that new safety information has been added to the label for Invirase (saquinavir, from Genentech), describing potentially life-threatening cardiac effects when used with Norvir (ritonavir, from Abbott).” View full resource at oncologynurseadvisor.com
Most Recently Shared on October 21, 2010 at 7:21 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Invirase labeling updated to include cardiac risk with Norvir http://goo.gl/fb/3HTNM
FDA reviews cardiac risk of Invirase in combination with Norvir - ONA
oncologynurseadvisor.com — “The FDA has notified healthcare professionals and patients that it is reviewing clinical trial data about a potentially serious effect on the heart associated with the use of Invirase (saquinavir, from Roche) in combination with Norvir (ritonavir, from Abbott).” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 23, 2010 at 9:09 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA reviews cardiac risk of Invirase in combination with Norvir http://goo.gl/fb/DyEy
FDA reviews cardiac risk of Invirase in combination with Norvir - MPR
empr.com — “The FDA has notified healthcare professionals and patients that it is reviewing clinical trial data about a potentially serious effect on the heart associated with the use of Invirase (saquinavir, from Roche) in combination with Norvir (ritonavir, from Abbott).” View full resource at empr.com
Most Recently Shared on February 23, 2010 at 9:07 pm By:
MPR News: FDA reviews cardiac risk of Invirase in combination with Norvir: The FDA has notified healthcare profess... http://bit.ly/bNJGxD
Invirase labeling updated to include cardiac risk with Norvir - MPR
empr.com — “The FDA announced that new safety information has been added to the label for Invirase (saquinavir, from Genentech), describing potentially life-threatening cardiac effects when used with Norvir (ritonavir, from Abbott).” View full resource at empr.com
Most Recently Shared on October 21, 2010 at 9:06 pm By:
MPR News: Invirase labeling updated to include cardiac risk with Norvir: The FDA announced that new safety informa... http://bit.ly/9u5okh
HIV Drug Combination Invirase Plus Norvir Can Cause Life Threatening Heart Problems
medicalnewstoday.com — “HIV antiviral medication Invirase (saquinavir) when taken in combination with Norvir (ritonavir), also an HIV antiviral, can increase the risk of life-threatening heart rhythm abnormalities, trigg” View full resource at medicalnewstoday.com
Most Recently Shared on October 22, 2010 at 9:08 pm By:
HIV Drug Combination Invirase Plus Norvir Can Cause Life Threatening Heart Problems: HIV antiviral medication Invi... http://mnt.to/f/3LDP
European Medicines Agency Concludes That Benefit-risk Balance Of Invirase Remains Positive
medicalnewstoday.com — “The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has reviewed all available data on Invirase (saquinavir) and the potential risk of arrhythmia, and concluded t” View full resource at medicalnewstoday.com
Most Recently Shared on October 25, 2010 at 10:24 am By:
MedicalNewsToday: European Medicines Agency Concludes That Benefit-risk Balance Of Invirase: http://bit.ly/95ph0o Full http://bit.ly/ctj2iu
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
